Log In
Print
BCIQ
Print
Print this Print this
 

Malarone, atovaquone/proguanil

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionOral combination of two componds that inhibit two different pathways of pyrimidine synthesis
Molecular Target Not available
Mechanism of ActionDNA synthesis inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationMalaria
Indication DetailsTreat malaria
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today